Table 2.
OR (95% CI) |
|||||
---|---|---|---|---|---|
Contrast | Drop in SBP of ≥20 mm Hg, N = 715 visits | Drop in DBP of ≥10 mm Hg, N= 494 visits | Rise in HR of ≥20 beats per minute, N = 1,879 visits | Consensus Definition: Either BP Criteria, N = 1,005 visits | Any Criteria (SBP, DBP, or HR), N = 2,824 visits |
Intensive vs Standard | 0.84 (0.58, 1.22) | 0.89 (0.60, 1.30) | 1.10 (0.90, 1.35) | 0.93 (0.68, 1.28) | 1.05 (0.88, 1.26) |
Metoprolol vs Ramipril | 1.71 (1.15, 2.53)* | 1.43 (0.96, 2.15) | 0.44 (0.35, 0.55)* | 1.58 (1.14, 2.20)* | 0.72 (0.59, 0.88)* |
Amlodipine vs Ramipril | 0.91 (0.50, 1.65) | 1.26 (0.74, 2.14) | 0.96 (0.74, 1.23) | 1.05 (0.65, 1.68) | 0.97 (0.76, 1.23) |
Metoprolol vs Amlodipine | 1.88 (1.04, 3.41)* | 1.14 (0.65, 1.99) | 0.46 (0.35, 0.60)* | 1.51 (0.93, 2.44) | 0.74 (0.58, 0.96) |
Note: Participants were assigned to one of six interventions: intensive-ramipril, intensive-metoprolol, intensive-amlodipine, standard-ramipril, standard-metoprolol, or standard-amlodipine. Models were adjusted for initial medication in the blood pressure goal comparisons, and adjusted for blood pressure goal in the initial medication comparisons.
P < 0.05